MENU
DNLI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Denali Therapeutics (DNLI) Ownership - Who owns Denali Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
161 Oyster Point Boulevard
Phone
+1 650 866-8548
Employees
445
Web
https://www.denalitherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.09B
P/E Ratio
N/A
Total Cash
836.56M
Projected Growth
N/A
Total Debt
52.52M
Revenue
N/A
Risk (Beta)
1.15
Dividend Yield
N/A
Total Cash/Share
5.81
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
DNLI
Capitalization
3.09B
P/E Ratio
N/A
Risk (Beta)
1.15
Dividend Yield
N/A
Total Cash
837M
Total Cash/Share
5.81
Total Debt
52.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.32B
P/B Ratio
2.34
Cash Flow
N/A
Earnings
-2.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.76M
Current Ratio
9.98
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-496.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.77
Shares Held By Institutions
5.34B
Shares Outstanding - Current
144M
Total Liabilities
136M
Total Volume MTD
N/A
Value
-1
Gain YTD
-0.047
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
161 Oyster Point Boulevard
Phone
+1 650 866-8548
Employees
445
Web
https://www.denalitherapeutics.com